Urotensin II alters vascular reactivity in animals subjected to volume overload

Peptides. 2010 Nov;31(11):2075-82. doi: 10.1016/j.peptides.2010.07.023. Epub 2010 Aug 17.

Abstract

Congestive heart failure (CHF) alters vascular reactivity and up regulates in urotensin II (UTII), a potent vasoactive peptide. The aim of this study was to investigate the interaction between CHF and UTII in altering vascular reactivity in a rat model of volume overload heart failure. Animals were divided into 4 groups: control, UTII infused (UTII), volume overload only (VO) or volume overload+UTII (VO+UTII). Volume overload was established by the formation of an aortocaval fistula. Following fistula formation animals were administered UTII at a rate of 300 pmol/kg/h for 4 weeks subcutaneously with mini-osmotic pumps. Thoracic aorta rings, with/without endothelium, were subjected to cumulative dose-responses to phenylephrine, sodium nitroprusside (SNP), acetylcholine (ACH), UTII, and the Rho-kinase inhibitor HA-1077. Aortas from VO animals exhibited increased sensitivity to phenylephrine and UTII with a decreased relaxation response to ACH and HA-1077. Aortas from animals subjected to chronic UTII with volume overload (VO + UTII) retained their sensitivity to phenylephrine and UTII while they improved their relaxation to HA-1077 but not ACH. The constrictive response to UTII was dose-dependent and augmented at concentrations <0.01 μM in VO animals. The changes in vascular reactivity paralleled an elevation of both the UTII and α(1A)-adrenergic receptor while the Rho and Rho-kinase signalling proteins were diminished. We found that volume overload increased sensitivity to the vasoconstrictor agents that was inversely related to changes in the Rho-kinase expression. The addition of UTII with VO reversed the constrictive vascular response through alterations in the Rho-kinase signalling pathway.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine / analogs & derivatives
  • Acetylcholine / pharmacology
  • Animals
  • Aorta, Thoracic / drug effects
  • Aorta, Thoracic / physiology
  • Aorta, Thoracic / surgery
  • Arteriovenous Shunt, Surgical / adverse effects
  • Cardiac Volume
  • Heart Failure / physiopathology*
  • Humans
  • Male
  • Models, Animal
  • Nitroprusside / pharmacology
  • Phenylephrine / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, G-Protein-Coupled / biosynthesis
  • Urotensins / pharmacology*
  • Vasoconstriction / drug effects
  • Venae Cavae / surgery
  • rho-Associated Kinases / antagonists & inhibitors

Substances

  • Receptors, G-Protein-Coupled
  • Urotensins
  • Uts2r protein, rat
  • Nitroprusside
  • Phenylephrine
  • 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
  • urotensin II
  • rho-Associated Kinases
  • Acetylcholine
  • fasudil